drugset / Trial / NCT06972576
Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of EphA2-targeted CAR-DC combined with CAR-T cell therapy in patients with non-small cell lung cancer.
Timeline
- Start
- 2025-05-09
- Primary completion
- 2026-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EphA2-targeted CAR-DCs | Cell therapy | — | — |
| Subject | EphA2-targeted CAR-T Cells | Cell therapy | — | — |